Silence Therapeutics plc
Status: Publicly traded
Direct answer
Silence Therapeutics plc is publicly traded on NASDAQ under the ticker SLN.
Silence Therapeutics plc is a London, UK-based biotechnology company specializing in the research and development of groundbreaking ribonucleic acid (RNA) therapeutics. Its therapeutic focus areas include hematological, cardiovascular, and various rare and metabolic conditions. Central to their innovative approach is the mRNAi GalNAc Oligonucleotide Discovery platform, which is designed for precise targeting of...
Can you invest in Silence Therapeutics plc?
Yes. Silence Therapeutics plc trades publicly on NASDAQ as SLN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Silence Therapeutics plc
Detailed equity research is provided by MarketSnap.